| Name | Izuralimab |
|---|
| Description | Izuralimab is a bispecific IgG1 antibody targeting inducible T-cell costimulator (ICOS/CD278) and PD-1[1]. |
|---|---|
| Related Catalog | |
| Target |
ICOS/CD278, PD-1[1] |
| References |
| No Any Chemical & Physical Properties |